Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory pharmacogenetic substudy of REGARD in relapsing multiple sclerosis
2009-016087-37Phase 4Completed
- Sponsor
- Merck Serono
- Start
- Nov 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in multiple sclerosis (MS) comparing Rebif with Copaxone (2 arms). Started Nov 2009; status: completed.
02
Drugs
interferon beta-1aglatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-016087-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016087-37.